CIK 0001933414 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Mineralys Therapeutics, Inc.
Sign in to watch- Ticker
- MLYS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 841966887
- Phone
- (888) 378-6240
- Business address
- 150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,403,032
- in 5 filings, $2.4M under 10b5-1 plans
Net −$5,403,032. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 62 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-21 | Warren Eric Chief Commercial Officer | Option exercise 10b5-1 | +7,438 | $13.24 | $98K | 45,838 |
| 2026-07-21 | Warren Eric Chief Commercial Officer | Sale 10b5-1 | −7,438 | $26.87 | $200K | 38,400 |
| 2026-07-21 | Warren Eric Chief Commercial Officer | Option exercise · Stock Option 10b5-1 | −7,438 | 245,438 | ||
| 2026-07-17 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +416 | $15.44 | $6K | 51,800 |
| 2026-07-17 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −416 | $26.53 | $11K | 51,384 |
| 2026-07-17 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −416 | 3,334 | ||
| 2026-07-15 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −6,349 | $26.61 | $169K | 51,384 |
| 2026-07-13 | Congleton Jon Chief Executive Officer | Sale 10b5-1 | −10,700 | $27.24 | $291K | 603,621 |
| 2026-07-13 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +3,542 | $10.20 | $36K | 61,275 |
| 2026-07-13 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +4,167 | $14.25 | $59K | 65,442 |
| 2026-07-13 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +6,349 | $1.08 | $7K | 71,791 |
| 2026-07-13 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −14,058 | $27.58 | $388K | 57,733 |
| 2026-07-13 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −3,542 | 109,792 | ||
| 2026-07-13 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −4,167 | 79,167 | ||
| 2026-07-13 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −6,349 | 0 | ||
| 2026-07-09 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +2,171 | $16.00 | $35K | 59,904 |
| 2026-07-09 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −2,171 | $30.30 | $66K | 57,733 |
| 2026-07-09 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −2,171 | 15,194 | ||
| 2026-06-30 | Congleton Jon Chief Executive Officer | Sale 10b5-1 | −58,000 | $25.94 | $1.5M | 631,321 |
| 2026-06-30 | Congleton Jon Chief Executive Officer | Sale 10b5-1 | −17,000 | $26.82 | $456K | 614,321 |
Page 2 of 17 · 321 trades